As the inhibitor of miR-200b/200a/429, LncRNA GIHCG was shown effectively promoting the progression of liver cancer through inducing methylation of miR-200b/200a/429 promoter (Sui et al., 2016). The gene discussed is GIHCG; the disease is liver cancer.